Allegheny Health Network
Find a
Doctor
Request An Appointment Login to
MyChart
Patient
Center
News Classes &
Events
Contact
Us
Call 412.Doctors

Active Clinical Trials

Registry Protocol TED-R13-002

Active NCT:
01990040
Allegheny General Hospital
Allegheny General Hospital

Category:
Digestive
Sponsor: 
NPS Pharmaceuticals, Inc.
Contact: 

For more information, please contact Donna Smith at 412-359-3095 or Donna.Smith2@ahn.org

Registry Protocol TED-R13-002: A Prospective, Multi-center Registry for Patients with Short Bowel Syndrome

Purpose: 

This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for patients with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in patients with SBS. SBS patients treated and not treated with teduglutide will be enrolled.

Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Sampling Method: Non-Probability Sample
Study Population
This registry is to enroll both male and female patients, of any age, with a diagnosis of SBS.

Criteria:
This is an observational registry study. Data will be collected during routine consultations and clinical staff will enter this information into a system at baseline (when a patient consents into the study) and approximately every 6 months following. Each patient will be followed for at least 10 years.